ACTA’s current Consumer Reimbursement and Remuneration Policy
Resource Documents
ACTA Consumer Reimbursement and Remuneration Policy
ACTA’s current Consumer Reimbursement and Remuneration Policy
PDFLatest Resource
-
Teletrials web resource
-
ACTA Masterclass 5: Consumer Engagement
-
Webinar recording: ICH GCP E6 (R3) guidelines: What’s New, What’s Changed, What’s Next!
-
ACTA Consumer Remimbursement and Remuneration Policy
-
Webinar recording: APT Virtual Clinic – ACT-GLOBAL Adaptive Platform Trial for Stroke
-
Workshop: How to better develop cross-network collaborations and linkages
-
The processes involved in a Data and Safety Monitoring Board/Committee with special reference to the role of the various statisticians
-
Webinar recording: National Clinical Trials Governance Framework: Update from sites that have been through accreditation
-
ACTA 2022-2023 Annual Report
-
ACTA Whistleblower Policy
-
HEAT webinar recording: Design of economic evaluations along the development process
-
Workshops and Virtual Clinics on Adaptive Platform Trials
-
Webinar recording: APT Virtual Clinic – the BAT and PASSPORT Trials
-
Exploring greater partnership between Clinical Trial Networks, Clinical Quality Registries and Trial Coordinating Centres with Industry
-
Value of clinical trials infographic
-
HEAT Webinar Recording-Flexible survival models and why we (might) need them
-
HEAT Webinar Recording- Use of Administrative Data for Measuring Events and Healthcare Use
-
Recommendations to improve cultural and linguistic diversity in clinical trials
-
Adaptive Platform Trial Summaries
-
Approaches to prioritising research
for clinical trial networks: a scoping review -
HEAT Webinar Recording- Economic Evaluation Alongside Adaptive Trials
-
ACTA 2021-2022 Annual Report
-
Effective strategies to manage data integrity risks webinar
-
The Data Lifecycle: Ethical use of data webinar
-
Transparency in data analyses webinar
-
Economic evaluation alongside cluster trial – webinar recording
-
Development of the Consumer Involvement and Engagement Toolkit
-
Activities supporting the growth of Clinical Trial Networks in Australia
-
Strengthening the capacity, efficiency and effectiveness of Clinical Trials Networks: Activity Overview 2017–2021
-
ACTA 2020-2021 Annual Report
-
MEDIA RELEASE: ACTA appoints Prof Steve Webb as its new Chair and Ian Wilson as Additional Independent Director
-
Official Opening of the 2020 ACTA Summit: Minister’s Address
-
ACTA Year in Review: Financial Year 2019-2020
-
Statistical Analysis Plan (SAP)
-
ACTA Board Charter
-
ACTA Constitution